HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Marat V Ezhov Selected Research

Cardiovascular Diseases (Cardiovascular Disease)

1/2024iPSC-Derived Endothelial Cells Reveal LDLR Dysfunction and Dysregulated Gene Expression Profiles in Familial Hypercholesterolemia.
10/2023Lipoprotein(a) and Low-Molecular-Weight Apo(a) Phenotype as Determinants of New Cardiovascular Events in Patients with Premature Coronary Heart Disease.
1/2023Lipoprotein(a) in an adult sample from the Russian population: distribution and association with atherosclerotic cardiovascular diseases.
1/2020An Exploratory Analysis of Proprotein Convertase Subtilisin/Kexin Type 9 Inhibition and Aortic Stenosis in the FOURIER Trial.
1/2020Therapeutic Apheresis for Management of Lp(a) Hyperlipoproteinemia.
1/2019Lipoprotein(a), PCSK9 Inhibition, and Cardiovascular Risk.
1/2019Effect of the PCSK9 Inhibitor Evolocumab on Total Cardiovascular Events in Patients With Cardiovascular Disease: A Prespecified Analysis From the FOURIER Trial.
6/2015Statin intolerance - an attempt at a unified definition. Position paper from an International Lipid Expert Panel.
3/2015Statin intolerance - an attempt at a unified definition. Position paper from an International Lipid Expert Panel.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Marat V Ezhov Research Topics

Disease

12Atherosclerosis
01/2024 - 08/2014
9Cardiovascular Diseases (Cardiovascular Disease)
01/2024 - 03/2015
8Coronary Disease (Coronary Heart Disease)
10/2023 - 10/2003
7Coronary Artery Disease (Coronary Atherosclerosis)
06/2023 - 06/2009
6Myocardial Infarction
12/2022 - 10/2003
4Hyperlipoproteinemia Type II (Familial Hypercholesterolemia)
01/2024 - 10/2018
3Inflammation (Inflammations)
01/2024 - 01/2021
3Hypertension (High Blood Pressure)
11/2023 - 10/2003
2Hypercholesterolemia
11/2023 - 05/2020
2Atherosclerotic Plaque (Atheroma)
10/2023 - 06/2009
2Dyslipidemias (Dyslipidemia)
10/2023 - 01/2019
2Hypertriglyceridemia
10/2023 - 01/2022
2Aortic Valve Stenosis (Aortic Stenosis)
03/2023 - 01/2020
2Stroke (Strokes)
11/2022 - 01/2019
2Hyperlipoproteinemias
10/2020 - 01/2020
2Chest Pain (Chest Pains)
11/2017 - 10/2003
2Hyperlipidemias (Hyperlipidemia)
11/2017 - 01/2013
2Skeletal Abnormalities Mandibular Hypoplasia Auditory Canal Atresia Short Stature
06/2015 - 03/2015
1Metabolic Syndrome (Dysmetabolic Syndrome X)
10/2023
1Ischemic Stroke
12/2022
1Calcinosis
11/2022
1Peripheral Arterial Disease
05/2020
1Type 2 Diabetes Mellitus (MODY)
01/2019
1Myocardial Ischemia (Ischemic Heart Diseases)
10/2018
1Carotid Artery Diseases
01/2016
1Acute Coronary Syndrome
06/2015
1Pathologic Constriction (Stenosis)
01/2013

Drug/Important Bio-Agent (IBA)

15Lipoprotein(a)IBA
10/2023 - 01/2013
8Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
11/2023 - 01/2013
7oxidized low density lipoproteinIBA
06/2023 - 01/2013
5LipidsIBA
11/2023 - 10/2003
5LDL CholesterolIBA
03/2022 - 11/2017
4Apolipoproteins AIBA
10/2023 - 08/2014
4evolocumabIBA
10/2020 - 01/2019
3CholesterolIBA
01/2024 - 10/2018
3Proprotein Convertase 9IBA
10/2023 - 10/2018
3omega-Chloroacetophenone (Mace)IBA
12/2022 - 02/2022
2Triglycerides (Triacylglycerol)IBA
10/2023 - 01/2019
2AutoantibodiesIBA
03/2023 - 01/2021
2LDL Lipoproteins (beta Lipoproteins)IBA
12/2022 - 10/2018
2Apoprotein(a) (Apolipoprotein (a))IBA
01/2022 - 10/2018
2Lipoproteins (Lipoprotein)IBA
11/2017 - 01/2013
2Atorvastatin (Lipitor)FDA Link
11/2017 - 01/2013
2Complement System Proteins (Complement)IBA
06/2015 - 03/2015
1LDL Receptors (LDL Receptor)IBA
01/2024
1Ezetimibe (Zetia)FDA Link
11/2023
1Fenofibrate (CiL)FDA LinkGeneric
10/2023
1Immunoglobulin M (IgM)IBA
03/2023
1Apolipoprotein C-II (ApoC2)IBA
01/2022
1Antigen-Antibody Complex (Immune Complex)IBA
01/2021
1C-Reactive ProteinIBA
01/2021
1Monoclonal AntibodiesIBA
10/2020
1HDL CholesterolIBA
01/2019
1Insulin (Novolin)FDA Link
01/2019
1PPAR alphaIBA
01/2019
1AN 12IBA
11/2017
1Rosuvastatin Calcium (Crestor)FDA Link
06/2009
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
06/2009
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
06/2009
1ApolipoproteinsIBA
10/2003

Therapy/Procedure

6Blood Component Removal (Apheresis)
01/2020 - 01/2013
3Coronary Artery Bypass (Coronary Artery Bypass Surgery)
11/2022 - 01/2013
3Percutaneous Coronary Intervention
11/2022 - 06/2009
3Therapeutics
01/2020 - 06/2009
2Myocardial Revascularization
06/2009 - 10/2003